Pulmonology Medical News about Aspergillus

Your Unread Messages

See All

Tracy Hampton, PhD

Clinical Trial Watch

Whole-Brain Radiation Affects Learning and Memory in Brain Cancer Patients

Roberta Buell, MBA
Medicare Final Rule for 2010

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

HPV Prevalence at Root of Racial Disparity in Head and Neck Cancer

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Aspergillus and the paediatric lung
Paediatric Respiratory Reviews, 11/06/09

Hatziagorou E et al. – Aspergilloma is managed by observation or surgery. IPA is predominantly seen in patients with haematological malignancies, chronic granulomatous disease or immunosuppressive treatment. With the use of aggressive therapies for end–stage CF, such as heart–lung transplantation, the potential for a patient to convert from colonization or ABPA to IPA has increased. Suggestive clinical and radiological findings, supplemented with mycological data using serology and molecular biology, have enhanced the capacity to diagnose IPA in paediatric patients.

<< Previous
Efficacy and safety of normal saline instillation: A systematic...

Next >>
QuantiFERON-TB Gold in the identification of latent tuberculosis...